142 related articles for article (PubMed ID: 35590116)
21. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
22. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological outcome of ovarian granulosa cell tumors.
Al-Rayyan E; Maaita M; Alelwan O; Taso O; Hadadin W
Gulf J Oncolog; 2018 Sep; 1(28):31-36. PubMed ID: 30344131
[TBL] [Abstract][Full Text] [Related]
24. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
25. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
26. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
28. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours.
Jia SZ; Zhang JJ; Liang ZY; Yang JJ; Xiang Y; Jia CW; Leng JH
BMC Cancer; 2018 Nov; 18(1):1160. PubMed ID: 30470202
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus.
Reichenbach J; Schmoeckel E; Mahner S; Trillsch F
J Ovarian Res; 2021 Jul; 14(1):89. PubMed ID: 34233728
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of borderline ovarian tumors in a Greek university hospital.
Liapis A; Bakalianou K; Iavazzo C; Salakos N; Paltoglou G; Kondi-Pafiti A
Eur J Gynaecol Oncol; 2008; 29(4):383-5. PubMed ID: 18714575
[TBL] [Abstract][Full Text] [Related]
32. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
33. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
34. Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study.
Ikeda Y; Yoshihara M; Yoshikawa N; Tamauchi S; Yokoi A; Nishino K; Niimi K; Kajiyama H
Int J Gynaecol Obstet; 2022 May; 157(2):437-443. PubMed ID: 34324200
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors.
Morice P; Camatte S; El Hassan J; Pautier P; Duvillard P; Castaigne D
Fertil Steril; 2001 Jan; 75(1):92-6. PubMed ID: 11163822
[TBL] [Abstract][Full Text] [Related]
36. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
[TBL] [Abstract][Full Text] [Related]
38. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
39. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.
Uzan C; Kane A; Rey A; Gouy S; Duvillard P; Morice P
Ann Oncol; 2010 Jan; 21(1):55-60. PubMed ID: 19608617
[TBL] [Abstract][Full Text] [Related]
40. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
Bell KA; Kurman RJ
Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
